Sartorius Stedim BioOutsource Contract Testing Facility in Glasgow Successfully Passes FDA Inspection
Certified quality of analytical services for developers of biologics and biosimilars
2 Mar 2016
Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, has announced that the Glasgow facility of its subsidiary Sartorius Stedim BioOutsource Ltd. has successfully passed an inspection by the U.S. Food and Drug Administration (FDA).
In January 2016, the FDA Compliance Safety Officer spent two days at BioOutsource’s facility reviewing its quality systems and their application to the analytical services that support the testing of biologics, vaccines and biosimilars. The inspection confirmed that the Glasgow site is compliant with the principles and guidelines of Good Manufacturing Practices (GMP). Not a single Form 483 observation for non-conformance was issued.
At the closing meeting, the FDA inspector was very satisfied with the facility and complimented Sartorius Stedim BioOutsource on its GMP systems, organization during inspection and the expertise of its team members. The success of this FDA inspection, combined with the positive feedback from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) in 2015, as well as reports from numerous biopharma clients that have visited and audited the Glasgow facilities in recent years, demonstrates BioOutsource’s commitment to maintaining excellence in its quality systems.
Gerry Mackay, CEO at BioOutsource stated: “We’re delighted with the positive outcome of our FDA inspection, because it shows that we are committed to offering quality analytical and safety testing. This provides biopharma firms with confidence that we are a partner they can trust with their biologic and biosimilar drug development programs.”
Related Products
Request Quote for All Products
BIOSTAT® B – The Gold Standard of Benchtop Bioreactors
Sartorius GroupThe BIOSTAT® B fermenter | bioreactor has been specially designed to cover the wide variety of requirements in biotechnological and biopharmaceutical research and development. With several thousands of units installed worldwide, BIOSTAT® B is the most successful autoclavable system of its class and is now available in the third generation. A wide range of configurations is available to choose from for animal, plant and insect cell cultivation as well as for microbial fermentation. The process controller can be combined either with reusable stirred glass vessels or with single-use bioreactors made of pre-sterilized polycarbonate. Volumes range from 1L to 2L and from 5L to 10L. The system is capable of controlling either one or two vessels completely independently from each other. Designed to meet your specific needs, BIOSTAT® B covers a wide range of applications, extending from use as a flexible basic unit for preclinical research to a fully qualified system that complies with the requirements of a validated GMP environment. Typical areas of application include the following: Process development for the manufacture of vaccines, recombinant proteins and monoclonal antibodies Process strategy development using a batch, fed-batch, continuous or perfusion mode Scale-up and scale-down tests for commercial-scale manufacture Small-scale (pre-)production High cell-density fermentation Adherent cell cultures on microcarriers Low-shear-stress cell cultivation of sensitive organisms Cultivation of filamentous organisms Biofuel manufacturing Dual usage both for cell cultures and microbial applications, such as in academic research
SARTOFLOW® Study
Sartorius GroupThe SARTOFLOW® Study will prove to be your best assistant in ultra- and diafiltration applications.This manual benchtop Crossflow system has been optimized for ultrafiltration, microfiltration and diafiltration applications used in many downstream processes. It will assist you by conveniently displaying interactive prompts for easy guidance through entire sequences. That will enable you to be more productive during the purification of monoclonal antibodies, vaccines or protein solutions.